XML 63 R52.htm IDEA: XBRL DOCUMENT v3.25.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
Sep. 30, 2024
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Goodwill [Line Items]        
Amortization $ 26,500,000   $ 27,700,000  
Non-cash impairment charges 0   7,064,000  
Expected annual amortization expense, remainder of 2025 79,600,000      
Expected annual amortization expense, in 2026 106,000,000.0      
Expected annual amortization expense, in 2027 105,000,000.0      
Expected annual amortization expense, in 2028 101,400,000      
Expected annual amortization expense, in 2029 96,200,000      
Expected annual amortization expense, in 2030 90,100,000      
Expected annual amortization expense, thereafter 439,200,000      
Intangible assets, net 1,187,535,000     $ 1,207,588,000
Completed technology        
Goodwill [Line Items]        
Cost, amortization 22,800,000   17,600,000  
Completed technology | Completed Technology, Surgimend        
Goodwill [Line Items]        
Intangible assets, net 31,000,000.0      
Completed technology | Completed Technology, PriMatrix        
Goodwill [Line Items]        
Intangible assets, net 23,300,000      
Customer Relationships        
Goodwill [Line Items]        
Non-cash impairment charges     $ 7,100,000 $ 7,100,000
Codman tradename        
Goodwill [Line Items]        
Impairment of indefinite-lived intangible assets 0      
Tissue Technologies        
Goodwill [Line Items]        
Fair value in excess of carrying amount, percent   21.20% 19.90%  
Impairment of goodwill 0      
Reporting unit, fair value increase (decrease), percent   (0.045)    
Neurosurgery        
Goodwill [Line Items]        
Fair value in excess of carrying amount, percent   11.70%    
Impairment of goodwill $ 0      
Reporting unit, fair value increase (decrease), percent   (0.038)    
Instruments        
Goodwill [Line Items]        
Fair value in excess of carrying amount, percent 22.10%      
Impairment of goodwill $ 0      
Reporting unit, fair value increase (decrease), percent   (0.035)    
Measurement Input, Long-Term Revenue Growth Rate | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input increase (decrease)   (50)    
Measurement Input, Long-Term Revenue Growth Rate | Tissue Technologies | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input   0.025 0.020  
Measurement Input, Long-Term Revenue Growth Rate | Neurosurgery | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input   0.025    
Measurement Input, Long-Term Revenue Growth Rate | Instruments | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input   0.025    
Measurement Input, Discount Rate | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input increase (decrease)   50    
Measurement Input, Discount Rate | Valuation Technique, Discounted Cash Flow | Codman tradename        
Goodwill [Line Items]        
Indefinite-lived intangible assets, measurement input 0.130      
Measurement Input, Discount Rate | Tissue Technologies | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input   0.125 0.145  
Measurement Input, Discount Rate | Neurosurgery | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input   0.120    
Measurement Input, Discount Rate | Instruments | Valuation Technique, Discounted Cash Flow        
Goodwill [Line Items]        
Reporting unit, measurement input   0.115